Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00775398 · ClinicalTrials.gov registry record
Observational Study Assessing the Impact of Exposure to THROMBIN-JMI® on Coagulation Parameters.
A clinical trial, sponsored by Pfizer.
- Completed
- Registry status
- 553
- Enrollment target
NCT00775398 is a clinical trial that has completed, run by Pfizer. The registered enrollment target is 553 participants.
The verdict
NCT00775398 has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- 553 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the effect of possible exposure to THROMBIN JMI® on activated partial thromboplastin time (aPTT) at 48 hours post surgery in subjects with likelihood of prior exposure to THROMBIN JMI® within the past 4 years.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 553 participants |
| Start Date | 2008-11 |
| Est. Completion | 2009-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00775398
The ClinicalTrials.gov registry entry for NCT00775398 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 553 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00775398 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00775398 about?
NCT00775398 is a clinical study titled "Observational Study Assessing the Impact of Exposure to THROMBIN-JMI® on Coagulation Parameters.". The purpose of this study is to assess the effect of possible exposure to THROMBIN JMI® on activated partial thromboplastin time (aPTT) at 48 hours post surgery in subjects with likelihood of prior exposure to THROMBIN JMI® within the past 4 years.
What is the current status of trial NCT00775398?
This trial is currently completed. The enrollment target is 553 participants. The study started on 2008-11. Estimated completion is 2009-11.
Who is sponsoring clinical trial NCT00775398?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.